More on GALT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+23.1% Growth)
- Ratings (8.0 Score)
- Holders

Upcoming Events

- Earnings (11/16/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Galectin Therapeutics (NQ:GALT)
Delayed: 3.20 +0.01 (0.31%)
Prev. Close $3.19  
Open$3.22 
52 Wk High$3.05 
52 Wk Low$0.49 
Day High$3.22 
Day Low$3.11 
P/E N/A  
EPS$-1.32 
Volume42,581 


Oct 13, 2026 08:01 AM Form ARS GALECTIN THERAPEUTICS For: Dec 31
Oct 13, 2026 08:01 AM Form DEFA14A GALECTIN THERAPEUTICS
Oct 13, 2026 08:00 AM Form DEF 14A GALECTIN THERAPEUTICS For: Dec 03
Oct 6, 2026 08:00 AM Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026
Oct 2, 2026 03:54 PM Form PRE 14A GALECTIN THERAPEUTICS For: Dec 03
Sep 10, 2026 08:00 AM Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Aug 14, 2026 08:00 AM Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update 
Aug 14, 2026 07:56 AM Form 8-K GALECTIN THERAPEUTICS For: Aug 14
Aug 14, 2026 07:51 AM Form 10-Q GALECTIN THERAPEUTICS For: Jun 30
Aug 4, 2026 08:30 AM Form SCHEDULE 13D/A GALECTIN THERAPEUTICS Filed by: Uihlein Richard E
View All Articles

Entities mentioned with GALT

View All Entities